E
LIVE

Serial Number

79398068

Owner

ESTEVE PHARMACEUTICALS, S.A.

Attorney

Todd A. Sullivan

Filing Date

May 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

E Trademark

Serial Number: 79398068 • Registration: 7772829

E is a trademark filed by ESTEVE PHARMACEUTICALS, S.A. on May 17, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ESTEVE PHARMACEUTICALS, S.A. (26 trademarks)

TORRE ESTEVE,

Entity Type: 99

Trademark Details

Filing Date

May 17, 2024

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Pharmaceutical preparations for medical and veterinary use for the treatment of respiratory diseases; hygienic and sanitary products for medical use; dietetic food adapted for medical or veterinary use, food for babies; food supplements for persons or animals; medical plasters; material for dental fillings and impressions; disinfectants; preparations for destroying vermin; fungicides, herbicides

Chemical products in the nature of industrial chemicals for industry, science and photography, as well as for agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compounds; metal tempering and soldering preparations; substances for tanning animal skins and hides, namely, tanning agents in the nature of oils for tanning leather; adhesives for use in industry; mastics, namely, mastic adhesives for tires; compost, manures, fertilizers; biological preparations for use in industry and science

Medical services; veterinary services; hygienic and beauty care treatments for humans or animals; horticulture services; pharmaceutical dispensary services, namely, preparation of prescriptions in pharmacies; health care services; providing medical information; veterinary information services; advice services relating to pharmaceutical products; medical information and medical consulting services relating to pharmaceutical products; medical and pharmaceutical consulting services

Scientific and technological services, as well as research services relating thereto, namely, scientific research and technological research in the field of pharmaceuticals; industrial research services in the field of pharmaceuticals; design and development of computer hardware and software; medical research services; chemical research services; pharmaceutical research services; development of pharmaceutical preparations and medicines; services for conducting clinical trials, namely, scientific research in the nature of conducting clinical trials for pharmaceutical products for others; evaluation of pharmaceutical products; providing medical and scientific research information in the pharmaceutical field

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 5, 2025 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 21, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 21, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 19, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 12, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 11, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 28, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR